Purpose Although urine is the most common matrix for prisoner drug testing, oral fluid offers a possible alternative. Identifying new drug intake by a prisoner results in negative sanctions. Detection times in oral fluid after chronic drug intake may be extended. Within the prison, admission population is chronic drug users. Our aim was to investigate detection windows for drugs of abuse in oral fluid from prisoners. Methods Nineteen frequent drug-abusing prisoners provided oral fluid and urine at admission and each morning thereafter for 9 consecutive days. Results The most positive findings were for amphetamine/methamphetamine, cannabis and benzodiazepines. Maximum detection times in oral fluid were ≥ 9 days for diazepam, methadone and methamphetamine, with corresponding urinary detection times of ≥ 9, 7 and 6 days, respectively. Maximum oral fluid detection times were 9 days for clonazepam, 8 for oxazepam, 3 for amphetamine and nitrazepam, and 2 for tetrahydrocannabinol, with positive urinary detection times of 8, ≥ 9, 5, 7 and ≥ 9 days, respectively. Cocaine, morphine and 6-acetylmorphine were all positive only 1 day in oral fluid; cocaine and morphine were positive 1 and 2 days, respectively, in urine, while 6-acetylmorphine was not detected in urine. Conclusion We confirmed oral fluid as a viable matrix for monitoring drugs of abuse in prisoners. Windows of detection for benzodiazepines and amphetamines were up to 1 week, which is an important consideration for evaluating oral fluid drug testing results. Some likely new drug exposures were observed based on urine and oral fluid drug results, but there were few data to guide these interpretations.
Introduction
Prisoners are frequently tested for drugs, with urine as the preferred matrix. Observed urine collections are time-consuming, and many donors regard it as an invasion of privacy. With the advances in analytical technology for oral fluid testing, this biological matrix is now a viable alternative to urine testing in several disciplines [1] [2] [3] [4] [5] . The easy, fast and gender-neutral oral fluid sample collection can take place in almost any location, with less embarrassment for the donor, giving oral fluid significant advantages over urine.
In Norway, urine is collected on admission to prison, and creatinine-corrected urine sample concentrations taken at regular intervals thereafter are interpreted to determine whether results are likely to represent new intake within the prison or residual excretion from intake before imprisonment. Replacement of urine with oral fluid as the testing matrix requires a scientific basis, and although data exist on drug elimination in oral fluid from controlled administration studies, these results may not be representative for samples collected from prisoners with chronic and/or high drug intake.
Windows of detection for drugs in oral fluid are considered to be short, and more similar to blood than urine [6, 7] . The detection periods are thus highly dependent upon both the chosen cut-off concentration and the dose ingested [8, 9] . Multiple studies have documented that oral fluid is a viable matrix for detection of drugs of abuse [10] [11] [12] [13] [14] [15] . Single and low doses were typically administered in controlled drug studies [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] , although others investigating drug elimination of purported high doses from patients admitted for drug detoxification [27] [28] [29] [30] or after chronic frequent use [31, 32] have reported increased drug detection times. Since many prisoners have a history of high-dose and/or chronic use of drugs of abuse before incarceration, elimination and detection times for these drugs in oral fluid from this population provide relevant data for future interpretation of oral fluid tests. The aim of this study was to investigate the windows of detection for drugs of abuse in oral fluid after possible highdose or chronic frequent drug use, by evaluating samples taken at the time of prisoner incarceration and on the following 9 days. Drug use is prohibited in prison, and inmates are under sustained, monitored abstinence.
Materials and methods

Study group
In total, 19 inmates from three prisons were enrolled in the study. Drug consumption prior to incarceration was selfreported. Information regarding prescribed drugs during the study was provided by the prison physician. The only relevant medications reported were buprenorphine and methadone for opioid dependence treatment and oxazepam.
Positive drug test results produced no negative consequences for participants, as the prisons did not receive the results. Participants received no payment for providing samples. Each participant had a unique code linked to their selfreport data and samples, and only one person in each prison had access to these data. Everyone else was blind to prisoner identity, and only participants' unique codes were reported.
Sample collection
Sampling occurred on the day of and for 9 days after prison admission (reported as day 0 to day 9), for a total of 10 oral fluid samples per participant. Since drug intake might have occurred on day 0, positive oral fluid samples collected on day 1 were considered as having a detection time of 1 day.
Oral fluid samples and, if possible, each first voided urine were collected each morning. Oral fluid samples were collected with the commercially available Intercept ® Oral Specimen Collection Device (OraSure Technologies, Bethlehem, PA, USA). The cotton pad on a stick was placed between the cheek and gum for 2 min to sample oral fluid according to the manufacturer's recommendations. All samples were weighed to obtain the amount of oral fluid collected. The collection pad contains preservatives and citric acid, stimulating oral fluid production, and collecting a mixture of saliva, gingival crevicular fluid and mucosal transudate. After collection, the pad was placed into a vial containing 0.8 mL stabilizing buffer solution and stored at −20 °C until analysis. The urine sample was collected in a 120-mL BD Vacutainer urine collection cup with an integrated transfer device (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) and transferred to Vacuette ® vials without additives (Med-Kjemi AS, Asker, Norway) before transport to the laboratory.
Analytical methods
Urine samples were screened for amphetamines, cannabis, cocaine, methadone, opiates (EMIT II Plus reagents; Siemens Healthcare AS, Oslo, Norway) and benzodiazepines (CEDIA reagents; Thermo Fisher Microgenics, Fremont, CA, USA) by immunological methods on the Hitachi 917 analyzer (Hitachi, Tokyo, Japan). In addition, pH (DRI ® pH-Detect Test; Thermo Fisher Microgenics) and creatinine (DRI ® Creatinine-Detect ® Test; Thermo Fisher Microgenics) were measured. γ-Hydroxybutyrate (GHB) was screened by ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) [33] . Confirmation analyses were performed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) for benzodiazepines [34] and UHPLC-MS/MS for opiates and cocaine [35] . Amphetamines, methadone and 11-nor-9-carboxy-Δ 9 -tetrahydrocannabinol (THCCOOH) were analysed by internally validated UHPLC-MS/MS and gas chromatography-mass spectrometry (GC-MS) methods, respectively. Oral fluid samples were analysed for drugs of abuse by a quantitative LC-MS/MS method [36] . Cutoff concentrations in oral fluid and urine are shown in Table 1 . Detailed validation data for oral fluid were given in our previous report [36] . Urine validation data for quantification of some metabolites of benzodiazepines, amphetamine, methamphetamine and THCCOOH are presented in Table 2 .
Statistics
The data were analysed using IBM SPSS Statistics 23.0 (IBM Corp., Armonk, NY, USA). Pearson's correlation was 1 3 used to investigate the relationship between concentrations in oral fluid and urine.
Results
Demographic data and self-reported prior drug intake for the 17 male and two female participants are shown in Table 3 . Fifteen subjects provided biological samples for all 10 days of the study, and the remaining four subjects for 5, 7, 8 and 9 days. The longest detection times for each drug and/or metabolite are reported in Table 4 . It is important to emphasize that drugs may have been consumed prior to admission (day 0), and for those drugs still detected on day 9, detection times might be longer, because later samples were not collected or analysed.
Amphetamine/methamphetamine
Amphetamine and methamphetamine were detected together in 11 participants' oral fluid and/or urine, while one participant's biological samples contained only amphetamine (subject 15), and one only methamphetamine (subject 5). Amphetamine was identified in oral fluid from days 0 to 3, and methamphetamine from days 0 to 9. Amphetamine was detected in urine from days 0 to 5, and methamphetamine from days 0 to 6. The longest amphetamine detection time was in urine, while for methamphetamine it was in oral fluid. As shown in Fig. 1 , the biological sample with the longest detection time varied between subjects. The prisoners self-reported previous amphetamine, but not methamphetamine use. If self-reported ingestion times were considered, detection times were longer, with a maximum of 10 days for amphetamine and 15 days for methamphetamine.
Opioids
Morphine and/or 6-monoacetylmorphine (6-AM) were detected in two participants' samples. Heroin is metabolized rapidly to 6-AM and morphine, and later morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G). Subject 8 self-reported heroin consumption the day before admission (day −1), and morphine, M3G and M6G were identified in the subject's urine through day 2 (Table 3) ; opioids were not detected in any of his/her oral fluid samples except for one subject. Subject 11 self-reported heroin ingestion 3 days before imprisonment (day −3); 6-AM was identified in oral fluid on day 0, but not in any urine samples. Morphine was detected in the oral fluid sample on day 0 and in urine until day 1. Considering the self-reported time of last exposure, the window of detection for morphine was 4 days in urine, and the detection time for morphine/6-AM was 3 days in oral fluid. These estimates, however, are uncertain.
Methadone was detected in samples from two participants. Subject 2 allegedly ingested massive amounts of drugs prior to admission (methadone, heroin, cannabis and diazepam; doses and times of ingestion were not given) and Table 1 Drug cutoff concentrations in oral fluid and urine
9 -tetrahydrocannabinol, THCCOOH 11-nor-9-carboxy-Δ 9 -tetrahydrocannabinol a Oral fluid concentrations in neat oral fluid, corrected for a 1+2 dilution by the buffer in the collection tube experienced a nonfatal overdose. Urine samples showed decreasing methadone concentrations detectable until day 7, and methadone was detected in oral fluid through day 9. The other participant, subject 4, received opioid-dependence treatment during the study, and no detection time window can be given. In all cases where buprenorphine was detected, it was given as opioid-dependence treatment. This makes it impossible to estimate the window of detection for buprenorphine.
Δ
-Tetrahydrocannabinol (THC)
In 15 participants, 11-nor-9-carboxy-Δ 9 -tetrahydrocannabinol (THCCOOH) was detected in urine on day 1. Of these, only two participants had detectable THC in oral fluid only on day 0. Seven participants had detectable THCCOOH in urine throughout the study. However, most participants claimed last cannabis intake several days before admission. One participant tested positive for THC in oral fluid on days 4 and 5, with prior negative samples. Oral fluid concentrations corrected for dilution were 7.7 and 14.2 µg/L, respectively. Urine creatinine-corrected THCCOOH increased from 15 ng/ mg on day 1 and < cut-off on day 2, to 78, 171 and 203 ng/ mg creatinine on days 3, 4 and 5, respectively. Day 3 urine concentrations were assessed as new cannabis intake using the reference values of U2/U1 ratios reported by Smith et al. [37] . Clearly positive THC results in oral fluid on days 4 and 5 also indicate new cannabis intake in prison (Fig. 2 ).
Benzodiazepines
Clonazepam
Clonazepam was identified in urine or oral fluid samples of seven subjects, none of whom received medical treatment with clonazepam in prison. Maximum clonazepam detection time was 8 days in urine (range 1-8 days), and at least 9 days in oral fluid (range 1-9 days), if the positive clonazepam samples for subject 15 on days 0 and 9 only are included. In one participant, clonazepam and 7-aminoclonazepam oral fluid concentrations on day 8 were 97 and 6.4 µg/L, respectively, while all prior urine and oral fluid samples were negative. This suggests new clonazepam intake after admission to prison.
Nitrazepam
Nitrazepam/7-aminonitrazepam were detected in the oral fluid of three participants. In urine, detection times ranged from 2 to 7 days, and in oral fluid from 1 to 3 days. Considering the subjects' self-reported last intake, the detection time did not change. Figure 3 shows the elimination curves for nitrazepam and 7-aminonitrazepam in oral fluid from participants 14 and 18, the prisoners with the longest detection times, and with the corresponding creatinine-normalized urine elimination curves for 7-aminonitrazepam. 
Oxazepam
Eleven participants had oxazepam in either urine or oral fluid. No information about doses was available for subject 7, who, according to our information, stopped taking oxazepam during the study; however, the date was not given. For subject 10, 25 mg Sobril ® was prescribed morning and evening during the study, making it impossible to determine detection times in either matrix. For the other inmates, oxazepam was found with other diazepam metabolites. Windows of detection for oxazepam ranged from 2 to ≥ 9 days in oral fluid and urine, with generally longer detection times in urine than oral fluid samples. Additionally, it was difficult to distinguish the source of oxazepam, as it is also a metabolite of other benzodiazepines including diazepam. One person (subject 14) disclosed oxazepam ingestion the day before incarceration to prison, with detection times of 6 days in oral fluid and 7 days in urine; however, the presence of other diazepam metabolites demonstrates intake of other benzodiazepine(s) as well.
Diazepam/N-desmethyldiazepam
Diazepam or metabolites were identified in the samples of eight inmates. Diazepam detection times in oral fluid ranged from 4 to ≥ 9 days, and in urine from 1 to ≥ 9 days. Participant 4 only had positive N-desmethyldiazepam in oral fluid, and 3-hydroxydiazepam and oxazepam in urine, and did not declare diazepam intake. For four participants, diazepam and its metabolites were detected in oral fluid for the entire study period, but there was no self-report of time of last intake. However, one person with positive samples during the entire study claimed that the last diazepam ingestion was at least 13 days before admission.
Cocaine
Cocaine and its metabolite benzoylecgonine were detected in subject 5's oral fluid and benzoylecgonine in a urine sample only on day 3, after negative tests the days before. Oral fluid concentrations corrected for dilution were 4.4 µg/L for cocaine and 9.9 µg/L for benzoylecgonine. In urine samples, cocaine was negative, while the benzoylecgonine concentration was 2262 µg/L and the creatinine-normalized result was 1122 ng/mg. This finding was interpreted as ingestion of cocaine after admission.
Correlation between oral fluid and urine results
Oral fluid and urine samples collected on the same days were compared. For most drugs, both matrices were initially positive, but last detection varied according to matrices. The longest detection time for the compound or a specific metabolite
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Cannabis was an exception, as there were many positive urine samples without matching positive oral fluid samples. For amphetamine, a trend towards longer detection time in urine could be seen, while methamphetamine tended to have longer detection times in oral fluid (Fig. 1) . Oxazepam had longer detection times in urine, while evaluation for N-desmethyldiazepam was difficult, as most samples were positive in both oral fluid and urine at the end of the study. For the other compounds, the number of cases was too small to infer any trends. A direct comparison of the quantitative results for oral fluid and creatinine-corrected urine concentrations for the four most prevalent drugs is shown in Fig. 4 . We used Pearson's correlation to investigate the relationship between concentrations in oral fluid and urine, and found correlation coefficients of 0.612 (methamphetamine), 0.314 (amphetamine), 0.535 (7-aminoclonazepam) and 0.553 (N-desmethyldiazepam). The correlations were significant (p < 0.01) for methamphetamine, 7-aminoclonazepam and N-desmethyldiazepam, but not (p = 0.086) for amphetamine. Table 4 The longest drug detection times in oral fluid and urine OF oral fluid, THC Δ 9 -tetrahydrocannabinol, THCCOOH 11-nor-9-carboxy-Δ 9 -tetrahydrocannabinol
The longest drug detection time in OF and urine during imprisonment is counted from the admission day. When the maximum number of days is ≥ 9, this means that sample(s) were positive on the last day of the study (day 9), and that the window of detection is at least 9 days a One sample was OF positive for clonazepam on admission day and day 9 only, with 7-aminoclonazepam above cutoff on admission day and days 1, 5 and 6 b THC in oral fluid only positive on admission day, except for one likely new intake, where it was positive on 2 days 
Discussion
We investigated the detection times for drugs of abuse in oral fluid and urine samples collected from 19 prisoners with a history of drug abuse, while under constant supervision. Individual elimination curves (Figs. 2 and 3 ) of creatininenormalized urine results were used for comparison to determine whether variation in oral fluid results was likely to be the result of new intake during the study. Greater variability was found in the elimination curves for oral fluid than in creatinine-corrected urine curves, in line with previous findings [27] [28] [29] [30] . In addition, for subjects with a history of high-dose and repeated drug use, detection times could be several days. Despite a significant correlation between oral fluid and urine concentrations for most of the drugs depicted in Fig. 4 , it is not possible to infer the concentration in urine from that in oral fluid and vice versa. At the end of the elimination curve of a drug, a positive sample following a negative sample can be found in any matrix, as the concentration fluctuates around the limits of quantification/detection (LOQs/LODs). Oral fluid concentrations tend to be more variable than blood concentrations, for example, and this effect is therefore more pronounced in oral fluid. Negative samples interspersed with positive findings were encountered for some in our study, which is consistent with other elimination studies [16, [27] [28] [29] [30] [31] . Detection times were longer than in controlled single-dose administration studies [16, 38, 39] . As many prison inmates have a chronic drug problem, these data are important, because they represent long-term high-dose intake of drugs based on self-report.
Benzodiazepines
Benzodiazepines are popular drugs of abuse, and are frequently included in drug testing programs. Few studies have investigated benzodiazepine detection windows in oral fluid [6, 7, 29, 40, 41] . A summary by Kidwell et al. [42] reported detection times of 48 and 70 h for diazepam and nitrazepam, respectively, after ingestion of single doses. This is comparable to the results of our previous study of patients undergoing drug detoxification, where diazepam was found as N-desmethyldiazepam in oral fluid for the entire 9 days, applying a cut-off of 1.3 µg/L [29] . Our current research revealed a window of detection for diazepam of at least 9 days in oral fluid and urine, and N-desmethyldiazepam had the longest detection time in oral fluid compared to urine. Detection times for clonazepam were at least 6 days in oral fluid and 8 days in urine (Table 4) . One participant was positive for clonazepam in oral fluid on admission day and day 9 only; 7-aminoclonazepam fluctuated around the cutoff, extending the detection time to at least 9 days in oral fluid. This is comparable to our previous study of patients undergoing drug detoxification, where 7-aminoclonazepam was detected for 6 days [29] , with a cut-off of 1.3 µg/L.
Few data are available regarding nitrazepam elimination in oral fluid. One study found a maximum concentration of 1.9 µg/L in oral fluid after administration of 5 mg nitrazepam, and the drug was quantifiable up to 70 h, with an LOQ of 0.5 µg/L [43] . As shown in Fig. 3 , we also found low (1-2.5 µg/L) initial nitrazepam concentrations, which decreased over 3 days. No data were provided about the time of nitrazepam intake in our study. Nitrazepam/7-aminonitrazepam was detected for 3 days in oral fluid and 7 days in (Table 4) , and 7-aminonitrazepam had higher concentrations than nitrazepam in all samples.
Opioids
We are aware of only one study that has investigated the oral fluid window of detection for heroin [30] , although others have reported that 6-AM is more frequently detected in oral fluid than in urine [44] . Opioids were found in samples from only two participants. In one case, 6-AM was detected in oral fluid but not in urine. In the other case, the opposite situation occurred. This indicates individual variability that must be taken into account when interpreting results. Our window of detection for methadone in oral fluid of at least 9 days (Table 3 , subject 2) is similar to the 8 days previously reported for one patient and longer than the 5 days for another in a study of patients undergoing drug detoxification [30] .
Amphetamines
Few studies have investigated windows of detection for amphetamines in oral fluid. Huestis and Cone [24] showed that after sequential daily dosing of 20 mg methamphetamine for 4 days, a clear accumulation of methamphetamine in oral fluid was observed. Positive specimens were reported for approximately 24 h at a cut-off of 2.5 µg/L. Schepers et al. [16] also reported detection times for amphetamine and methamphetamine in oral fluid of up to 24 h at the same cut-off after a 20-mg dose of methamphetamine. Methamphetamine was measurable for 36-72 h after the last of four doses. As could be expected assuming higher intake, we found a much (Table 4) . This is slightly longer than in our previous study of patients undergoing drug detoxification, where the detection window was up to 8 days [27] . For amphetamine, a shorter detection window of up to 3 days was found (Table 4) , as compared to the previously reported detection window of up to 8 days for patients undergoing drug detoxification [27] . It may be difficult to differentiate the effects of amphetamine and methamphetamine [45] ; thus there was consistency between the participants' self-reports regarding methamphetamine/amphetamine ingestion and the actual findings in oral fluid/urine.
THC
THC is metabolized to the inactive metabolite THCCOOH, which can be detected in urine for weeks after stopping chronic frequent cannabis intake [46] . Lee et al. [31] showed that the detection time for THC in oral fluid among chronic frequent cannabis smokers ranged from 48 h to 28 days, with negative samples (< 0.5 µg/L) interspersed with a few positive samples, raising the possibility of reuse despite 24-h surveillance on a closed research unit. In patients undergoing detoxification, Andås et al. [28] reported an 8-day oral fluid THC window of detection (0.3 µg/L LOQ). In the present study, a 0.9-µg/L cutoff was applied, and THC was detected in oral fluid samples from only two subjects, with the longest detection time of 1 day. The difference could be attributable in part to a higher cut-off, but it could also indicate that the participants in the studies by Lee et al. [31] and Andås et al. [28] had greater and more frequent cannabis intake. New cannabis intake was suggested for subject 5, with similar findings of THC in oral fluid and urine on days 4 and 5 after admission (Fig. 2) . These data support the use of oral fluid as a matrix for revealing drug use in prison. However, the aforementioned possibility of negative samples interspersed with positive findings must also be considered [31] .
Cocaine/benzoylecgonine
Cocaine or benzoylecgonine were identified in the oral fluid samples of only one participant, subject 5, on day 3 (Table 3) ; these results were interpreted as new cocaine intake in prison. The transfer of cocaine from blood to oral fluid depends on oral fluid pH. Cocaine has a short detection time in oral fluid, as is also the case for this analyte in blood and urine [22, 47, 48] .
Limitations
Limitations of the study include the number of participants and single oral fluid and urine samples each day. However, valuable oral fluid detection time data from individuals with histories of potentially high and repeated drug intake are included, as well as comparisons of paired oral fluid and urine data. Limited studies investigated this population. Detection times for benzodiazepines and amphetamines in oral fluid were consistent with or somewhat longer than those previously reported, while detection times for opiates and THC were shorter. It is important to emphasize that the study period was 10 days, allowing for maximum detection times of at least 9 days (Table 4) , while intake was varied prior to imprisonment.
Conclusions
Oral fluid was a viable alternative to urine for monitoring drugs of abuse in prison. Oral fluid is easier to collect and much less likely to be subject to adulteration than urine. Our study confirmed that long detection times, especially for amphetamines and benzodiazepines, could be encountered in this population, although cannabinoid detection was much less prevalent in oral fluid than in urine tests. The study results indicate that it might be possible to identify new drug intake from daily oral fluid concentrations, but elimination curves were not as consistent as those seen in blood [49] or creatinine-corrected urine. Negative oral fluid samples may be interspersed with positive findings, as noted with urine samples, especially when concentrations are close to applied cut-offs.
